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CASE REPORT 
Primary localised laryngeal amyloidosis  
- an atypical presentation 
 
Justine Borg, Gerd Xuereb, Kurt Apap, Charles Borg                
Primary localised laryngeal amyloidosis is a rare disease that 
classically presents with dysphonia. We present a case of a 38-year-
old woman who presented with a history of early morning 
haemoptysis, progressively worsening hoarseness and intermittent 
dysphagia. A bulky left false vocal cord was seen on examination. A 
computed tomography scan of the neck and trunk revealed 
thickening of the left side of the larynx with associated asymmetry. 
Direct laryngoscopy showed a round, well-circumscribed lesion on 
the left false vocal cord and histological examination of the lesion 
confirmed the presence of amyloid.  
Systemic disease was ruled out and the patient was treated with 
endoscopic excision of the mass through carbon dioxide laser 
technology. The patient’s symptoms improved and the patient is 
being followed up yearly to exclude disease recurrence. The report 
highlights the presentation, diagnosis and appropriate management 
of localised laryngeal amyloidosis.  
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INTRODUCTION 
Dysphonia, dysphagia and haemoptysis are 
common complaints in the ENT clinic, however 
localised amyloidosis causing this 
symptomatology is rare. This report describes 
the management of a patient with a benign 
disorder presenting with worrying symptoms.  
Amyloidosis is a rare condition that progresses 
relatively slowly and constitutes a variety of 
heterogeneous disorders defined by abnormal 
deposits of extracellular fibrillar proteins. The 
deposition of amyloid in various organs and 
tissues around the body invariably causes 
organ dysfunction over time.1 
Localized amyloidosis can be demonstrated in 
a single organ in the absence of systemic 
involvement and is typically benign in nature 
when isolated to an individual area in the head 
and neck region. Amyloid can be deposited at 
any laryngeal site however the true vocal cord 
is believed to be the most commonly 
affected.2 
CASE PRESENTATION 
A 38-year-old previously healthy woman 
presented to the Ear, Nose and Throat (ENT) 
department with a one-week history of early 
morning haemoptysis. The patient also 
complained of a six-month history of 
progressively worsening hoarseness and a 
shorter history of intermittent dysphagia. The 
patient, who previously smoked 20 cigarettes a 
day, initially attributed her hoarseness to 
smoking. The patient quit smoking in the three 
months before presentation, to no effect. Indirect 
laryngoscopy showed a bulky left false vocal cord. 
History and examination were otherwise 
unremarkable. 
A computed tomography (CT) scan of the neck 
and trunk revealed thickening of the left side of 
the larynx with associated asymmetry (Figure 1, 
Figure 2). The thickening was characterised by 
loss of fat plane between the left side of the larynx 
and the thyroid cartilage anteriorly. A 7mm 
nodule straddling the longus colli muscles was 
observed, which was most likely in keeping with 
a Thornwaldt cyst.  No abnormal enhancing of 
soft tissue and no loco-regional 
lymphadenopathy was noted. The base of tongue, 
parotid and submandibular glands appeared 
normal. No features of concern were observed 
elsewhere 
Direct laryngoscopy revealed a round, well-
circumscribed lesion on the left false vocal 
cord (Figure 3). The true vocal cord was visible 
underneath. Multiple biopsies were taken and 
sent for histology. 
Histological examination of the left false vocal 
cord lesion showed the presence of amyloid. 
This was demonstrated by the staining of 
amorphous material with Congo red that 
displayed apple-green birefringence when 
viewed under high-intensity cross-polarised 
light. Amyloid deposits were present 
throughout. Vascular proliferation of stroma, 
which was covered by normal looking 
respiratory epithelium was also observed. Mild 
chronic inflammation with no evidence of 
atypia was noted. 
 Immunohistochemical staining of the amyloid 
deposits was performed using monospecific 
antibodies reactive with serum Amyloid A 
protein (SAA), apolipoprotein A1 (apoA1), 
Transthyretin (TTR) and with kappa and 
lambda immunoglobulin light chains. The 
amyloid stained with antibodies to lambda 
light chains. This confirmed amyloid of AL type 
(lambda subtype). 
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Figure 1 A CT scan of the neck showing thickening of the left side of the larynx. The arrow 
  points towards the mass on the left false vocal cord. 
 
 
Figure 2 A CT scan of the neck showing thickening of the left side of the larynx with associated 
  asymmetry 
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Serum Protein Electrophoresis showed no 
indication of an increase in free light chains, 
however an elevated kappa/lambda ratio was 
observed. A full blood count, renal profile, liver 
profile, serum paraproteins, CRP, serum 
albumin and NT-proBNP were within normal 
limits. An electrocardiogram (ECG) and an 
echocardiogram were normal with no evidence 
of cardiac amyloidosis. A bone marrow biopsy  
excluded an underlying plasma cell dyscrasia 
as there was no evidence of plasma cell clone. 
A CT scan of the thorax showed no thoracic 
involvement. Serum Amyloid P (SAP) 
scintigraphy was unremarkable. These 
investigations ruled out systemic amyloidosis.  
The patient was diagnosed with localised 
laryngeal amyloidosis affecting the left false 
vocal cord. She was treated with endoscopic  
excision of the mass using carbon dioxide laser 
technology. The patient had an initial good 
response to treatment, however later 
complained about the development of a 
gravelly quality to her voice. Endoscopy 
showed a 0.5cm cyst overlying the left false 
vocal cord and was treated with a further two 
laser procedures. As a consequence to laser 
therapy, a granuloma was seen on follow up 
but this healed spontaneously. The symptoms 
resolved following the third laser procedure 
and the patient is being followed up once 
yearly.  
 
Figure 3 Direct laryngoscopy showing thickening of the left false vocal cord. 
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DISCUSSION 
Primary localised amyloidosis of the larynx is 
very rare accounting for only 1% of benign 
laryngeal tumours.3 It is characterised by the 
deposition of monoclonal light chains of the 
AL type.4 Two theories have been described to 
give an explanation for the development of 
localised laryngeal amyloidosis. The first 
theory proposes that amyloid light chains are 
produced by plasma cell clones while the other 
theory is centred around the body’s inability to 
remove light chain proteins leading to 
localized deposits.5 
Amyloidosis typically presents non-specifically 
in patients aged 50 to 70 years old and has a 
preponderance for males over females with a 
ratio of 3:1.5 In this case, our 38 year old female 
patient, presented with a sole nodule on the 
left false vocal cord. Other sites such as the 
orbits, the eyes and the salivary glands can also 
be affected. Submucosal deposits may be 
present in the oral cavity, stomatopharynx, 
nasopharynx, bronchotracheal tree and lungs 
as well as the nose, nasopharynx and paranasal 
cavities.6 
Our patient presented with atypical 
symptoms. The most common presenting 
complaint in patients suffering from laryngeal 
amyloidosis is worsening hoarseness.3 
Symptoms such as cough and dyspnoea are 
also frequently observed, however dysphagia 
and haemoptysis are rarely reported.3 Keeping 
in mind that laryngeal cancer can present 
similarly, a high index of clinical suspicion 
together with the appropriate investigations 
are needed to rule out the possibility of 
laryngeal cancer.1 
Systemic involvement should be excluded and 
therefore causes of systemic disease such as 
rheumatic disease and tuberculosis must be 
ruled out. Typically, systemic amyloidosis 
involves the kidneys, affecting approximately 
70% of patients, with nephrotic range 
proteinuria leading to renal failure in 50% of 
patients. It also affects the heart causing 
cardiomyopathy in around 60% of patients, 
manifesting as a thick-walled heart, low 
voltage ECG and pleural and pericardial 
effusions. Other forms of systemic 
involvement include cholestatic hepatopathy, 
peripheral and autonomic neuropathy, 
purpura and soft tissue infiltration, of which 
macroglossia is pathognomonic.7 
Plasma cell dyscrasias, which include, 
Waldenström macroglobulinemia and multiple 
myeloma can also lead to amyloidosis and 
should therefore be looked for.5 The build-up 
of abnormal amyloid protein leads to organ 
dysfunction. Therefore, in contrast to localised 
amyloidosis, systemic amyloidosis which 
affects various body organs, normally carries a 
very poor prognosis. Confirming the extent of 
amyloidosis guides management and serves to 
reassure the patient.1 
The treatment of choice for localised laryngeal 
amyloidosis is surgery, ideally aided by laser 
technology. First line therapy involves 
endoscopic excision of the mass using carbon 
dioxide laser.8 Spontaneous remission leaving 
no evidence of disease is possible however 
disease recurrence is a much more common 
outcome and therefore long-term follow up is 
advised for a minimum of 5 years.3 
KEY MESSAGES 
1. Primary localised laryngeal amyloidosis is a 
rare phenomenon that normally presents 
with hoarseness. However, physicians 
should be aware that it can also present 
with dysphagia and haemoptysis.  
2. Hoarseness should not always be attributed 
to smoking and should be investigated to 
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rule out underlying pathology. Laryngeal 
amyloidosis should be considered as part of 
the differential diagnosis in patients 
presenting with persistent dysphonia.  
3. Localised amyloidosis has a very high rate of 
recurrence and complications secondary to 
laser treatment may arise. Long-term follow 
up for a minimum of 5 years is therefore 
advised.  
 
4. Localised laryngeal amyloidosis can present 
very similarly to laryngeal cancer. Physicians 
should have a reasonable degree of 
suspicion for both diagnoses and should 
confirm the diagnosis with a biopsy. 
5. Localised and systemic amyloidosis have 
very different clinical outcomes, prognosis 
and management. Systemic involvement 
should therefore always be ruled out. 
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